Bard Financial Services Inc. lowered its position in shares of CVS Health Co. (NYSE:CVS - Free Report) by 10.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 141,857 shares of the pharmacy operator's stock after selling 15,700 shares during the quarter. Bard Financial Services Inc.'s holdings in CVS Health were worth $6,368,000 as of its most recent filing with the SEC.
Several other hedge funds also recently made changes to their positions in CVS. Hotchkis & Wiley Capital Management LLC grew its holdings in CVS Health by 34.8% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator's stock worth $748,085,000 after acquiring an additional 3,071,613 shares during the period. State Street Corp boosted its position in shares of CVS Health by 3.6% during the 3rd quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator's stock worth $3,554,475,000 after purchasing an additional 1,989,066 shares in the last quarter. TOMS Capital Investment Management LP acquired a new position in shares of CVS Health during the 3rd quarter worth $121,987,000. Pathway Financial Advisers LLC lifted its stake in shares of CVS Health by 5,864.2% in the third quarter. Pathway Financial Advisers LLC now owns 1,730,343 shares of the pharmacy operator's stock valued at $108,804,000 after purchasing an additional 1,701,331 shares during the period. Finally, AQR Capital Management LLC boosted its holdings in CVS Health by 33.5% during the second quarter. AQR Capital Management LLC now owns 5,289,788 shares of the pharmacy operator's stock worth $310,722,000 after buying an additional 1,327,855 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the stock. Barclays reduced their price target on shares of CVS Health from $75.00 to $71.00 and set an "overweight" rating for the company in a research report on Thursday, November 7th. Royal Bank of Canada decreased their target price on CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a research report on Friday, November 15th. UBS Group lifted their price target on CVS Health from $60.00 to $62.00 and gave the stock a "neutral" rating in a research note on Thursday, November 7th. Piper Sandler lowered their price objective on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a research note on Monday, November 25th. Finally, Cantor Fitzgerald restated a "neutral" rating and set a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have assigned a buy rating to the company's stock. According to data from MarketBeat, CVS Health has a consensus rating of "Moderate Buy" and an average target price of $68.71.
Read Our Latest Research Report on CVS Health
CVS Health Trading Up 0.1 %
CVS traded up $0.05 during midday trading on Monday, hitting $45.82. The company's stock had a trading volume of 16,458,742 shares, compared to its average volume of 13,094,375. The firm has a market cap of $57.66 billion, a P/E ratio of 11.63, a PEG ratio of 0.85 and a beta of 0.59. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $83.25. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The firm has a 50-day moving average price of $52.63 and a two-hundred day moving average price of $56.97.
CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. During the same quarter in the prior year, the business posted $2.21 earnings per share. CVS Health's revenue for the quarter was up 6.3% compared to the same quarter last year. On average, research analysts anticipate that CVS Health Co. will post 5.32 earnings per share for the current year.
CVS Health Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 5.81%. CVS Health's dividend payout ratio (DPR) is 67.51%.
CVS Health Company Profile
(
Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Articles
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
